EUVIMEDEUVIMED entdecken
Crossref

L26/P-867 How natural are your natural cycle frozen embryo transfers? An international survey of clinicians and embryologists

A. Anwar, H.S Ehgal, C.A. Fazakarley, S. Lane, D. Badran, A. Freis, N. Vermeulen, Y. Lauwers, H.S. Nielsen, D. Cimadomo, L.S. Brentjens, S. Mackens und 2 weitere

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.1191 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von A. Anwar und 13 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question What is the global variability in the definition and protocol of natural cycle frozen embryo transfer (NC-FET) offered to patients undergoing assisted reproductive technology (ART)? Summary answer There is substantial variation in how NC-FET is defined and implemented across clinics, making outcome data impossible to compare. What is known already According to the 2019 European IVF Monitoring (EIM) Consortium report for ESHRE, FET accounts for one-third of all ART cycles. Although medicated cycles have traditionally been the standard, NC-FET is increasingly used, with evidence demonstrating comparable pregnancy and live birth rates (LBRs). NC-FET has been associated with reduced maternal and neonatal morbidity, including lower rates of pre-eclampsia, caesarean section, and postpartum haemorrhage. However, there is no consensus on what constitutes an NC-FET protocol, with wide variation in the use of hCG trigger injections and luteal phase support (LPS), resulting in heterogeneity in reported reproductive outcomes and limited comparability across studies. Study design, size, duration ESHRE distributed a cross-sectional online survey evaluating current protocols and practice in NC-FET to 10,081 members via two email mailings and social media. Anonymous responses were collected between June 10 and July 18, 2025, migrated into SPSS, and analysed descriptively, with results reported as frequencies and percentages. Participants/materials, setting, methods The questionnaire developed by the ESHRE Special Interest Group on Implantation and Early Pregnancy (SIGIEP) included 50 questions covering respondent demographics and clinical practices, with a focus on NC-FET protocols. Topics addressed included ovulation induction, ovulation monitoring strategies, use of hCG trigger injections, endometrial assessment, LPS, embryo transfer timing, and the rationale for clinicians’ practices, as well as challenges and barriers associated with NC-FET. Respondents were clinicians or embryologists actively involved in ART. Main results and the role of chance 736 responses from 83 countries were analysed, with most respondents based in Europe (57.1%) and Asia (21.6%). Majority worked in private centres (63.4%) and were consultant doctors (78.6%). NC-FET was performed in 94% of centres, with a median reported LBR per embryo transfer of 38% (IQR 15). The proportion of NC-FET cycles varied considerably, with one quarter of centres reporting ≥80% of their FET cycles were NC-FET. Clinical practices varied substantially between centres. Ovulation induction was used by 48.9% of centres, commonly with letrozole. Almost all centres performed ultrasound endometrial assessment (97.9%), often using an endometrial thickness threshold of 7–8mm to proceed with transfer. Ovulation triggering was reported by 72.4% of centres, primarily for scheduling purposes. Monitoring strategies differed, with ultrasound most used (74.1%), followed by serum hormone measurements (63.4%) and home urinary LH testing (27.6%). LPS was prescribed by 93.5% of centres, typically using progesterone pessaries and often individualised according to progesterone levels. Blastocyst transfer was commonly performed on day 6 post-LH surge. NC-FET was chosen for fewer side effects, perceived higher success rates, and lower costs, with patient preference also influential. Reported barriers included unpredictable ovulation (44.5%), increased monitoring requirements (31.0%), and lack of clear guidelines (8.5%). Limitations, reasons for caution Potential limitations include self-reported data, selection bias, and incomplete responses. Variation in resources and regional regulations may also confound findings. Wider implications of the findings These results highlight the need for standardised definitions and harmonised protocols to enable comparison of outcomes within the context of individualised treatment strategies. Heterogeneity in terminology and practice limits interpretation and generalisability of evidence. International consensus would improve research quality, strengthen evidence-based guidelines, and enhance clinical decision-making and patient counselling. Trial registration number No

Zitieren

APA

Anwar, A., Ehgal, H., Fazakarley, C., Lane, S., Badran, D., Freis, A., Vermeulen, N., Lauwers, Y., Nielsen, H., Cimadomo, D., Brentjens, L., Mackens, S., Vomstein, K., & Tempest, N. (2026). L26/P-867 How natural are your natural cycle frozen embryo transfers? An international survey of clinicians and embryologists. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1191

Vancouver

Anwar A, Ehgal H, Fazakarley C, Lane S, Badran D, Freis A, et al. L26/P-867 How natural are your natural cycle frozen embryo transfers? An international survey of clinicians and embryologists. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1191

BibTeX
@article{Anwar2026,
  author = {Anwar, A. and Ehgal, H.S and Fazakarley, C.A. and Lane, S. and Badran, D. and Freis, A. and Vermeulen, N. and Lauwers, Y. and Nielsen, H.S. and Cimadomo, D. and Brentjens, L.S. and Mackens, S. and Vomstein, K. and Tempest, N.},
  title = {L26/P-867 How natural are your natural cycle frozen embryo transfers? An international survey of clinicians and embryologists},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.1191}
}
Kostenlos starten →